Role of Type I Interferons on Filovirus Pathogenesis

Vaccines
Beatriz Escudero-Pérez, César Muñoz-Fontela

Abstract

Filoviruses, such as Ebola and Marburg virus, encode viral proteins with the ability to counteract the type I interferon (IFN-I) response. These IFN-I antagonist proteins are crucial to ensure virus replication, prevent an antiviral state in infected and bystander cells, and impair the ability of antigen-presenting cells to initiate adaptive immune responses. However, in recent years, a number of studies have underscored the conflicting data between in vitro studies and in vivo data obtained in animal models and clinical studies during outbreaks. This review aims to summarize these data and to discuss the relative contributions of IFN-α and IFN-β to filovirus pathogenesis in animal models and humans. Finally, we evaluate the putative utilization of IFN-I in post-exposure therapy and its implications as a biomarker of vaccine efficacy.

References

Oct 5, 2001·Clinical Microbiology Reviews·C E Samuel
Feb 21, 2002·The Journal of Experimental Medicine·Winfried BarchetUlrich Kalinke
Mar 5, 2003·Cellular Microbiology·Kiyoshi Takeda, Shizuo Akira
Jun 28, 2003·Journal of Virology·Christopher F BaslerAdolfo García-Sastre
Sep 10, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kenya HondaTadatsugu Taniguchi
Sep 23, 2003·Nature Immunology·Agnes Le BonDavid F Tough
May 13, 2006·Science·Adolfo García-Sastre, Christine A Biron
May 16, 2006·Journal of Virology·St Patrick ReidChristopher F Basler
Jun 21, 2006·Proceedings of the National Academy of Sciences of the United States of America·Shoudong LiGanes C Sen
Jul 20, 2006·PLoS Pathogens·Hideki EbiharaYoshihiro Kawaoka
Dec 8, 2006·Journal of Virology·Iris KoernerPeter Staeheli
Jun 26, 2007·PLoS Pathogens·Joost HaasnootBen Berkhout
Jul 25, 2009·Virology·Christina F SpiropoulouSuryaprakash Sambhara
Aug 4, 2009·PLoS Pathogens·Jonathan S TownerPierre E Rollin
Aug 22, 2009·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·Christopher F Basler, Gaya K Amarasinghe
Sep 1, 2009·The Journal of Immunology : Official Journal of the American Association of Immunologists·Bruno MoltedoThomas M Moran
Apr 20, 2010·Journal of Molecular Biology·Daisy W LeungGaya K Amarasinghe
Nov 19, 2010·Lancet·Heinz Feldmann, Thomas W Geisbert
Feb 18, 2011·Journal of Virology·Charalampos Valmas, Christopher F Basler
Jul 12, 2011·Nature Immunology·Helder I NakayaBali Pulendran
Oct 9, 2012·The Journal of Clinical Investigation·Julie HelftMiriam Merad
Dec 21, 2012·The Journal of Infectious Diseases·Lauren M SmithChristopher L Karp
Sep 28, 2013·Advances in Immunology·Muzlifah HaniffaFlorent Ginhoux
Jun 25, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·José V Pérez-GirónCésar Muñoz-Fontela
Oct 14, 2014·Expert Review of Vaccines·Karen Ao MartinsAndres M Salazar

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
nuclear translocation
transgenic
gene-knockout

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.